Avillion Appoints Kathryn J. Gregory as Chief Business Officer

Ms Gregory will be based in the US and will be focused on expanding the clinical co-development opportunities for Avillion.

Ms Gregory has over 25 years of executive leadership experience in biotechnology and pharmaceutical industries. She has extensive experience in international business development including corporate strategy, negotiation, mergers & acquisitions, and operational experience in marketing, strategic sourcing and procurement.

Please find the full press release here.

TwitterLinkedInEmailPrint